Federal contract award
75N93022C00018
GODX-SBIR PHASE I AWARD
Award details
Obligations, current value and potential value describe different measures; they are never added together.
| Field | Reported value |
|---|---|
| Agency | Department of Health and Human Services |
| Office | NATIONAL INSTITUTES OF HEALTH NIAID |
| NAICS | 541714 — Research and Development in Biotechnology (except Nanobiotechnology) |
| PSC | 6550 — In Vitro Diagnostic Substances, Reagents, Test Kits and Sets |
| Parent award / vehicle | Not reported |
| Set-aside | NO SET ASIDE USED. |
| Pricing type | FIRM FIXED PRICE |
| Obligations | $1.6M |
| Current contract value | $1.6M |
| Potential contract value / ceiling | $1.6M |
| Start date | Jul 1, 2022 |
| Current end date | Dec 31, 2025 |
| Potential end date | Dec 31, 2025 |
| Latest award activity | Sep 22, 2025 |
| Source loaded | Sep 26, 2026 |
Funding and modification history
Showing the latest 5 of 5 loaded transactions. Negative values are deobligations.
| Date | Modification | Obligation change | Description |
|---|---|---|---|
| Sep 22, 2025 | P00004 | $0 | RAPID, LOW-COST, POINT-OF-CARE DIAGNOSTIC TO DETECT ENTERIC PATHOGENS AND ANTIBIOTIC RESISTANCE |
| May 23, 2025 | P00003 | $-200.0K | EOI:: IMPLEMENTING THE PRESIDENT'S DEPARTMENT OF GOVERNMENT EFFICIENCY COST EFFICIENCY INITIATIVE (MARCH 19, 2025)::EOI. PARTIAL TERMINATION |
| Jun 9, 2023 | P00002 | $1.5M | GODX-POINT-OF-CARE DIAGNOSTIC |
| Jun 5, 2023 | P00001 | $0 | GODX-POINT-OF-CARE DIAGNOSTIC |
| Jul 1, 2022 | 0 | $299.8K | GODX-SBIR PHASE I AWARD |
Research next steps
- Check the stated set-aside against the solicitation and current certifications.
- Review the award scope and buyer evidence before making a bid/no-bid decision.